1. Home
  2. CLPS vs ALGS Comparison

CLPS vs ALGS Comparison

Compare CLPS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CLPS Incorporation

CLPS

CLPS Incorporation

HOLD

Current Price

$0.82

Market Cap

29.6M

Sector

Technology

ML Signal

HOLD

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$5.53

Market Cap

33.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLPS
ALGS
Founded
2005
2018
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6M
33.0M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
CLPS
ALGS
Price
$0.82
$5.53
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$39.33
AVG Volume (30 Days)
37.5K
68.5K
Earning Date
03-06-2026
05-05-2026
Dividend Yield
14.76%
N/A
EPS Growth
N/A
88.30
EPS
N/A
N/A
Revenue
N/A
$2,186,000.00
Revenue This Year
N/A
$32.20
Revenue Next Year
N/A
$4.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$4.80
52 Week High
$1.88
$13.69

Technical Indicators

Market Signals
Indicator
CLPS
ALGS
Relative Strength Index (RSI) 34.38 50.92
Support Level N/A $4.80
Resistance Level $1.00 $5.94
Average True Range (ATR) 0.06 0.39
MACD -0.02 0.07
Stochastic Oscillator 8.60 63.54

Price Performance

Historical Comparison
CLPS
ALGS

About CLPS CLPS Incorporation

CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: